Praxis Precision Medicines

United States
Primghar, Iowa, United States, 02142

Company profile

Praxis Precision Medicines company profile

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.

Business identity

Phone number
(617)949-2220
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2015-09-22

Headquarters

Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$1.7B
Last funding
Post IPO Equity / $575M / 2026-01-06
Last equity funding
Post IPO Equity / $575M
Investors
15
Lead investors
1
Founders
3
Articles
251
Exited on
2020-10-15

Founders and investors

Founders

David GoldsteinKiran ReddySteven Petrou

Lead investors

Eventide

Investors

Adage Capital ManagementCormorant Asset ManagementNovo HoldingsPoint72 VenturesVida Ventures